IWWM-11 2022 | Novel treatment approaches in WM: the promise of immunotherapies
Stephen Ansell
• 28 Oct 2022
Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, briefly discusses novel treatment approaches in Waldenström’s macroglobulinemia (WM), drawing focus on the promise of immunotherapies including CAR-T cell therapy and bispecific antibodies. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research funding from Seattle Genetics, BMS, Affimed, Regeneron, Takeda, AstraZeneca, Pfizer, ADC Therapeutics to my institution for clinical trials.
